A human cytomegalovirus (HCMV) glycoprotein B (gpUL55) DNA vaccine has been evaluated in BALB/c mice. Intramuscular immunization of these mice with pRc/CMV2-gB resulted in the generation of high levels of gpUL55-specific antibody (geometric mean titer [GMT] 1:8900) and neutralizing antibody (GMT 1:74) after 2 booster doses given 5 and 10 weeks after primary inoculation. Emulsifying the construct with the aluminum phosphate gel adjuvant Adju-Phos before immunization enhanced gpUL55-specific antibody responses (GMT 1:17800, P¼0.04). Coimmunization with CpG oligodeoxynucleotides was shown to enhance levels of neutralizing antibodies generated by immunization of mice with a pRc/CMV2-gB/Adju-Phos emulsion (P¼0.04). The results provide a ration...
Introduction: Traditional vaccine strategies are inefficient at protecting against more complex path...
Vaccination has had great success in combating diseases, especially infectious diseases. However, tr...
There is now convincing evidence that the successful development of an effective CMV vaccine will re...
The immunogenicity of a vaccine formulation consisting of recombinant-derived human cyto-megalovirus...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
DNA vaccine has become an attractive approach for generating antigen-specific immunity. Targeting an...
Human cytomegalovirus infects the majority of humanity which may lead to severe morbidi-ty and morta...
Successful vaccination against the human cytomegalovirus (HCMV) requires induction. of both neutrali...
is partially attributable to the adjuvant properties of bacterial plasmid DNA (pDNA) for B lympho-cy...
Abstract Background Hepatitis B vaccine adjuvant, alum, is generally used for vaccination although i...
DNA vaccines can induce both humoral and cellular immune responses in animals. However, DNA vaccines...
A prophylactic vaccine to prevent the congenital transmission of human cytomegalovirus (HCMV) in new...
Subunit antigens of viruses and other infectious agents in their natural configuration can be produc...
Since neutralizing antibodies (NAb) targeting the human cytomegalovirus (HCMV) pentamer complex (PC)...
Introduction: Traditional vaccine strategies are inefficient at protecting against more complex path...
Vaccination has had great success in combating diseases, especially infectious diseases. However, tr...
There is now convincing evidence that the successful development of an effective CMV vaccine will re...
The immunogenicity of a vaccine formulation consisting of recombinant-derived human cyto-megalovirus...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
DNA vaccines expressing the envelope (Env) protein of the human immunodeficiency virus have been rel...
DNA vaccine has become an attractive approach for generating antigen-specific immunity. Targeting an...
Human cytomegalovirus infects the majority of humanity which may lead to severe morbidi-ty and morta...
Successful vaccination against the human cytomegalovirus (HCMV) requires induction. of both neutrali...
is partially attributable to the adjuvant properties of bacterial plasmid DNA (pDNA) for B lympho-cy...
Abstract Background Hepatitis B vaccine adjuvant, alum, is generally used for vaccination although i...
DNA vaccines can induce both humoral and cellular immune responses in animals. However, DNA vaccines...
A prophylactic vaccine to prevent the congenital transmission of human cytomegalovirus (HCMV) in new...
Subunit antigens of viruses and other infectious agents in their natural configuration can be produc...
Since neutralizing antibodies (NAb) targeting the human cytomegalovirus (HCMV) pentamer complex (PC)...
Introduction: Traditional vaccine strategies are inefficient at protecting against more complex path...
Vaccination has had great success in combating diseases, especially infectious diseases. However, tr...
There is now convincing evidence that the successful development of an effective CMV vaccine will re...